Updates are available Correction dated 2019-10-17
Click to view Correction: https://doi.org/10.1186/s13017-019-0268-8
-
Authors
,
Doig, Christopher J.
Page, Stacey A
McKee, Jessica L.
Moore, Ernest E.
Abu-Zidan, Fikri M.
Carroll, Rosemary
Marshall, John C.
Faris, Peter D
Tolonen, Matti
Catena, Fausto
Coccolini, Federico
Sartelli, Massimo
Ansaloni, Luca
Minor, Sam F.
Peirera, Bruno M.
Diaz, Jose J
Kirkpatrick, Andrew W. http://orcid.org/0000-0002-1692-5919
- License Information
-
More Information
Article History
Received: 13 June 2019
Accepted: 24 July 2019
First Online: 5 August 2019
Change Date: 17 October 2019
Change Type: Correction
Change Details: The original article [1] contained a typo in author, Federico Coccolini’s name. This has now been corrected.
Ethics approval and consent to participate
: Although the current work is a review without applicable ethical requirements, the COOL trial has been ethically approved at the lead and pilot center by the Conjoint Health Research Ethics Board (CHREB) of the University of Calgary (REB16-1588). The study has also been registered with the National Institutes of Health ( Identifier: NCT03163095).
: Not applicable
: JLM is the Clinical Research Director for Innovative Trauma Care, San Antonio, Texas, and has consulted for the Canadian Forces, Acesco Company, Acelity Corporation, and SAM Medical Corporation. EEM reported consulting for Haemonetics, Instrumentation Laboratory, Stago, Humacyte, and Prytime, with all proceeds paid to the University of Colorado. AWK serves in the Canadian Forces Medical Services and has consulted for the Innovative Trauma Care and Acelity Corporations. The other authors declare that they have no competing interests.
